Submit Your Feeds

Business News • PR NewsWire • Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease

Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease

IRVING, Texas, Nov. 11, 2010 /PRNewswire/ -- Reata Pharmaceuticals today announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD) and type 2 diabetes. The data will be presented in

View More : http://www.prnewswire.com/news-releases/reata-pharmaceuticals-to-present-data-from-pivotal-phase-2b-trial-in-type-2-diab...
Releted News by prnewswire
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease
Bank of America Donates $50,000 for Program to Enhance Employment and Training Opportunities for Vets
Construction Commences on Pennsylvania Dairy Farm Waste Management System Which Will Produce Cost-Effective, Permanent, Measurable and Verifiable Nutrient Reductions to the Chesapeake Bay
Home Sitemap Contact Us
© businessNewsNewsNews.com